Nevolat — UK Patient Information
Important information for UK consumers
Nevolat is a prescription-only medicine (POM) in the UK. UK regulations restrict the advertising of prescription medicines to the public. This page is general patient information about Nevolat — not an advertisement, not an offer of sale, and not medical advice. Nevolat may only be supplied with a valid UK prescription from a registered prescriber after a clinical assessment, and must be dispensed by a GPhC-registered pharmacy. TreatCompare does not display UK prices for Nevolat.
Nevolat (liraglutide) is a daily injectable GLP-1 receptor agonist manufactured by Zentiva. It is the generic equivalent of Saxenda, which has been discontinued, and contains the same active ingredient at the same dose.
Prices are verified regularly and may change between checks.
Compare your route
Choose your next step for Nevolat
Visitors usually need NHS eligibility context, a provider directory for a consultation, or information about side effects and dose schedules.
What to discuss with a UK prescriber
- Whether Nevolat is clinically appropriate for your circumstances.
- Whether NHS-funded treatment is realistic before paying privately.
- The dose escalation schedule and how tolerability is monitored.
- Common and serious side effects, and what to do if they occur.
- The follow-up review schedule and ongoing monitoring requirements.
- What is included in the consultation fee versus the prescription / dispensing fee.
- Any pathology, blood-test or specialist-referral costs likely to arise.
Service-level cost components
A private weight-management consultation in the UK can involve several service-level cost components. The medicine itself is priced separately by the dispensing GPhC-registered pharmacy and is not shown on TreatCompare’s consumer pages.
| Component | Pattern |
|---|---|
| Consultation fee | Clinical assessment by a UK-registered prescriber. |
| Prescription / clinical-assessment fee | Often bundled with the consultation; sometimes charged separately. |
| Pharmacy dispensing fee | Paid to the dispensing GPhC-registered pharmacy per script. |
| Follow-up review fee | Periodic clinical review during ongoing treatment. |
| Programme model fee | Some telehealth services bundle several of the above into one monthly fee. |
| Adjacent costs | Pathology, blood tests, specialist referrals, dietitian input. |
Nevolat is a prescription-only medicine. A clinical consultation with a UK-registered prescriber is required before it can be dispensed by a GPhC-registered pharmacy. This page does not provide medical advice.
UK regulatory framework
Can I get Nevolat on the NHS or do I need to pay privately?
- Nevolat is a UK medicine — NHS access depends on the specific indication and current NICE / NHS England commissioning. Speak to your GP for local availability.
- NHS prescription charge in England: £9.90 per item. Free in Scotland, Wales and Northern Ireland.
Public funding terms in United Kingdom: NHS eligibility, NICE guidance, ICB access. Source bodies: NHS England, NICE.
Check NHS eligibilityHow to compare providers safely
Lower-cost is not always safest. Use this checklist before paying for Nevolat from any United Kingdom provider — verifying the regulator, the inclusions, and the follow-up arrangements.
- Is the pharmacy registered with GPhC (check the register)?
- Is the clinic CQC-regulated where it provides healthcare services?
- If a named doctor is involved, are they on the GMC register?
- Is the medicine MHRA-authorised — and is the indication on-label?
- Is the price clear before you commit to payment?
- Are consultation, delivery and follow-up costs included or itemised separately?
- Are side effects, contraindications and dose escalation explained on the page?
- Are refund and cancellation terms visible before purchase?
- Are higher-dose prices visible, or only the starter dose?
- Are discount terms (first-month, subscription, code expiry) clear?
- Is there a way to contact the provider for clinical questions?
- Has the provider verified BMI / health-screening evidence before prescribing?
- Is the dose escalation schedule explained at the consultation?
- Is cold-chain delivery used (refrigerated transport)?
- Are needles and a sharps bin included or supplied separately?
- Is ongoing clinical follow-up included for the duration of treatment?
- Are MHRA Yellow Card safety reports discussed at the consultation?
Avoid unsafe or fake sellers
The following patterns are common to fake or unsafe Nevolat sellers in United Kingdom. A missing voluntary badge alone is not a red flag, but multiple of these signals together is.
- No prescription or clinical consultation required
- Unusually low price compared with the rest of the market
- Bulk-sale or "stack discount" offers on a prescription medicine
- Social-media-only seller with no fixed business address
- Payment requested by bank transfer or cryptocurrency
- No published refund or cancellation terms
- No contact details, complaint route or named clinician
- No cold-chain delivery information for refrigerated medicines
- No GPhC or CQC registration shown for the dispensing entity
- Imported product or "loose" pen sales — these typically bypass MHRA-authorised supply
How TreatCompare collects and checks prices
TreatCompare is a comparison and information service — we do not sell medicines or provide personalised medical advice. Prices on this page are collected from United Kingdom provider websites, normalised to weekly and monthly cost where relevant, and shown alongside the regulatory checks below. Always verify the final price with the provider before purchase.
United Kingdom regulatory checks
- ·Pharmacy registration verified against the GPhC register
- ·Clinic registration verified against the CQC register where applicable
- ·Where a named doctor is involved, the GMC register is consulted
- ·Medicine status checked against the MHRA authorisation route
- ·Public access framing follows NHS England and NICE guidance
Compare next
Mounjaro patient information
Tirzepatide — UK patient information
Mounjaro vs Wegovy
Mechanism, efficacy and side effects compared
UK weight-loss service-cost guide
Service-level cost components, no medicine prices
NHS eligibility checker
See whether NHS-funded treatment is realistic
GLP-1 side-effects data
UK MHRA Yellow Card reporting
Guides & articles
In-depth guides and cost breakdowns from the TreatCompare editorial team.
Nevolat in the UK: Patient Information
General patient information about Nevolat (liraglutide) in the UK, the generic equivalent of Saxenda. Not an advertisement and not medical advice.
Nevolat: The UK Saxenda Replacement (Patient Information)
Patient information about Nevolat (liraglutide), the generic equivalent of Saxenda in the UK. Not an advertisement and not medical advice.
GLP-1 Weight-Management Medicines in the UK: Patient Information (2026)
Patient information about the GLP-1 receptor agonists used for weight management or type 2 diabetes in the UK — Mounjaro, Wegovy, Ozempic, Rybelsus, Nevolat. No prescription-medicine prices.
How to Get Mounjaro in the UK: Patient Information (2026)
Patient information about UK NHS and private routes for Mounjaro (tirzepatide). Not an advertisement and not medical advice.
Mounjaro in the UK: Patient Information
General patient information about Mounjaro (tirzepatide) in the UK and the service-level cost components of a UK private weight-management consultation. Not an advertisement and not medical advice.
Mounjaro Maintenance Dose in the UK: Patient Information
General patient information about the Mounjaro (tirzepatide) maintenance-dose phase in the UK. Not an advertisement and not medical advice.
Spotted an error on this page? Tell us via the corrections route.